Document is current
Any future updates will be listed below
-
Authors
Xu, Jiaming
Guo, Zhenli
Zhao, Jie
Chen, Yun
Liu, Zhijun
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 20 October 2024
First Online: 17 January 2025
Declarations
:
: This study does not involve any research with human or animal subjects. Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
